New treatment to slow muscle wastag… – Information Centre – Research & Innovation

A medication developed by EU-funded researchers has been accepted to take care of little ones with the degenerative and lethal genetic disorder Duchenne muscular dystrophy. A major clinical trial is envisioned to announce positive benefits shortly.

Homelessness has come to be a social disaster and general public health issue all-around the planet, impacting folks of all ages. Most homeless folks are deprived by acquiring far less resources, and they may well or may well not have suitable health insurance plan. Psychological ailment and material abuse are common challenges in the homeless community, and folks dwelling on the streets have a substantial chance of building coronary heart condition. Still they have very little skill to choose treatment of their health.

A new study posted in Mayo Clinic Proceedings examined in-healthcare facility outcomes and thirty-working day readmission rates

Read More

Highmark launches technology-enabled opioid treatment program in West Virginia

Highmark West Virginia is giving its members obtain to a technological innovation-enabled opioid use ailment program intended to extend  cure to rural and underserved parts and deal with the shortage of accessible medication–assisted cure remedy.

The purpose of treatment-assisted cure remedy is to allow for folks to end abusing opioids with no experiencing highly effective drug cravings or intense withdrawal.

The remedy has also been proven to lower health prices. When opioid-dependent clients are on treatment-assisted treatment plans, health-associated prices lower by $twenty,000 per year, according to Bright Heart health, which is working in partnership with Highmark.

With the member’s

Read More